Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Rudloff Website

Udo Rudloff, M.D., Ph.D.

Selected Publications

1)  Abate-Daga D, Lagisetty KH, Tran E, Zheng Z, Gattinoni L, Yu Z, Burns WR, Miermont AM, Teper Y, Rudloff U, Restifo NP, Feldman SA, Rosenberg SA, Morgan RA.
A Novel Chimeric Antigen Receptor Against Prostate Stem Cell Antigen Mediates Tumor Destruction in a Humanized Mouse Model of Pancreatic Cancer.
Hum. Gene Ther. [Epub ahead of print], 2014.
[Journal]
2)  Beane JD, Yang JC, White D, Steinberg SM, Rosenberg SA, Rudloff U.
Efficacy of Adjuvant Radiation Therapy in the Treatment of Soft Tissue Sarcoma of the Extremity: 20-year Follow-Up of a Randomized Prospective Trial.
Ann. Surg. Oncol. [Epub ahead of print], 2014.
[Journal]
3)  Lau C, Killian KJ, Samuels Y, Rudloff U.
ERBB4 mutation analysis: emerging molecular target for melanoma treatment.
Methods Mol. Biol. 1102: 461-80, 2014.
[Journal]
4)  Rudloff U, Langan RC, Mullinax JE, Beane JD, Steinberg SM, Beresnev T, Webb CC, Walker M, Toomey MA, Schrump D, Pandalai P, Stojadinovic A, Avital I.
Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: Results of the GYMSSA trial.
J Surg Oncol. 110: 275-84, 2014.
[Journal]
5)  Schaub NP, Alimchandani M, Quezado M, Kalina P, Eberhardt JS, Hughes MS, Beresnev T, Hassan R, Bartlett DL, Libutti SK, Pingpank JF, Royal RE, Kammula US, Pandalai P, Phan GQ, Stojadinovic A, Rudloff U, Alexander HR, Avital I.
A novel nomogram for peritoneal mesothelioma predicts survival.
Ann. Surg. Oncol. 20: 555-61, 2013.
[Journal]
6)  Jia J, Parikh H, Xiao W, Hoskins JW, Pflicke H, Liu X, Collins I, Zhou W, Wang Z, Powell J, Thorgeirsson SS, Rudloff U, Petersen GM, Amundadottir LT.
An integrated transcriptome and epigenome analysis identifies a novel candidate gene for pancreatic cancer.
BMC Med Genomics. 6: 33, 2013.
[Journal]
7)  Langan RC, Gill F, Raiji MT, Mullinax JE, Pittaluga S, Pandalai P, Davis J, Perkins K, Avital I, Rudloff U.
Autoimmune pancreatitis in the autoimmune lymphoproliferative syndrome (ALPS): a sheep in wolves' clothing?.
Pancreas. 42: 363-6, 2013.
[Journal]
8)  Xin H, Ambe CM, Hari DM, Wiegand GW, Miller TC, Chen J, Anderson AJ, Ray S, Mullinax JE, Koizumi T, Langan RC, Burka D, Herrmann MA, Goldsmith PK, Stojadinovic A, Rudloff U, Thorgeirsson SS, Avital I.
Label-retaining liver cancer cells are relatively resistant to sorafenib.
Gut. 62: 1777-86, 2013.
[Journal]
9)  Langan RC, Sherry RM, Avital I, Heller T, Henderson C, Holland SM, Freeman AF, Rudloff U.
Safety of Major Abdominal Surgical Procedures in Patients with Hyperimmunoglobulinemia E (Job"s Syndrome): a Changing Paradigm?.
J. Gastrointest. Surg. 17: 1009-14, 2013.
[Journal]
10)  Langan RC, Lagisetty KH, Atay S, Pandalai P, Stojadinovic A, Rudloff U, Avital I.
Surgery for Li Fraumeni Syndrome: Pushing the Limits of Surgical Oncology.
Am. J. Clin. Oncol. [Epub ahead of print], 2013.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 8/15/2014.